0
0

Chapter 13. Alcohol and Other Depressant Drugs

John J. Mariani, M.D.; David E. Smith, M.D.; Donald R. Wesson, M.D.; Sanjay A. Sabnani

Sections

Excerpt

Perhaps the hardest step in treating alcoholism is to help patients recognize that alcohol is causing repetitive difficulties in their lives. One of the challenges is that many people gauge their own problem and intake pattern based on the habits of those around them (Daeppen et al. 1999). Because so many alcoholic people have both alcoholic relatives and heavy-drinking friends, the process of getting them in tune with the risks of continued drinking can be daunting.

Your session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Figure 13A–1. Timeline for determining independence of psychiatric symptoms for patients in treatment for alcoholism.
Table Reference Number
Table 13A–1. Features of motivational interviewing
Table Reference Number
Table 13A–2. DSM-IV-TR alcohol-induced disorders
Table Reference Number
Table 13B–1. Characteristics of syndromes related to benzodiazepine withdrawal
Table Reference Number
Table 13B–2. Benzodiazepines and their phenobarbital withdrawal equivalents
Table Reference Number
Table 13B–3. Sedative-hypnotics and their phenobarbital withdrawal equivalents

References

American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000
 
Brown SA, D'Amico EJ: Outcomes of alcohol treatment for adolescents. Recent Dev Alcohol 15:307–327, 2001
[PubMed]
 
Carroll KM, Nich C, Ball SA, et al: One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment. Addiction 95:1335–1349, 2000
[PubMed]
 
Daeppen JB, Smith TL, Schuckit MA: How would you label your own drinking pattern overall? An evaluation of answers provided by 181 high functioning middle-aged men. Alcohol Alcohol 34:767–772, 1999
[PubMed]
 
Fawcett J, Kravitz HM, McGuire M, et al: Pharmacological treatments for alcoholism: revisiting lithium and considering buspirone. Alcohol Clin Exp Res 24:666–674, 2000
[PubMed]
 
Fleming MF, Mundt MP, French MT, et al: Brief physician advice for problem drinkers: long-term efficacy and benefit-cost analysis. Alcohol Clin Exp Res 26:36–43, 2002
[PubMed]
 
Henggeler SW, Schoenwald SK, Pickrel SG: Multisystemic therapy: bridging the gap between university- and community-based treatment. J Consult Clin Psychol 63:709–717, 1995
[PubMed]
 
Johnston LD, O'Malley PM, Bachman JG: Monitoring the Future National Survey Results on Drug Use, 1975–2001, Vol 1: Secondary School Students. Rockville, MD, National Institute on Drug Abuse, 2002
 
Kiefer F, Jahn H, Tarnaske T, et al: Comparing and combining naltrexone and acamprosate in relapse prevention for alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 60:92–99, 2003
[PubMed]
 
Kranzler HR, Del Boca F, Korner P, et al: Adverse effects limit the usefulness of fluvoxamine for the treatment of alcoholism. J Subst Abuse Treat 10:283–287, 1993
[PubMed]
 
Krystal JH, Cramer JA, Krol WF, et al: Naltrexone in the treatment of alcohol dependence. N Engl J Med 345:1734–1739, 2001
[PubMed]
 
Marlatt GA, Gordon JR: Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York, Guilford, 1985
 
Mason BJ: Treatment of alcohol-dependent outpatients with acamprosate: a clinical review. J Clin Psychiatry 62 (suppl 20):42–48, 2001
 
Morgenstern J, Longabaugh R: Cognitive-behavioral treatment for alcohol dependence: a review of evidence for its hypothesized mechanisms of action. Addiction 95:1475–1490, 2000
[PubMed]
 
O'Brien CP, McLellan AT: Myths about the treatment of addiction. Lancet 347:237–240, 1996
[PubMed]
 
O'Farrell TJ, Choquette KA, Cutter HSG: Couples relapse prevention sessions after behavioral marital therapy for male alcoholics: outcomes during the 3 years after starting treatment. J Stud Alcohol 59:357–370, 1998
[PubMed]
 
Pollock N, Martin C: Diagnostic orphans: adolescents with alcohol symptoms who do not qualify for DSM-IV abuse or dependence diagnoses. Am J Psychiatry 156:897–901, 1999
[PubMed]
 
Project MATCH Research Group: Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcohol Clin Exp Res 22:1300–1311, 1998
 
Rohde P, Lewinsohn PM, Seeley JR: Psychiatric comorbidity with problematic alcohol use in high school students. J Am Acad Child Adolesc Psychiatry 35:101–109, 1996
[PubMed]
 
Schuckit MA: Drug and Alcohol Abuse: A Clinical Guide to Diagnosis and Treatment, 5th Edition. New York, Kluwer Academic/Plenum, 2000
 
Schuckit MA, Tipp JE, Reich T, et al: The histories of withdrawal convulsions and delirium tremens in 1648 alcohol dependent subjects. Addiction 90:1335–1347, 1995
[PubMed]
 
Schuckit MA, Tipp JE, Bergman M, et al: Comparison of induced and independent major depressive disorders in 2,945 alcoholics. Am J Psychiatry 154:948–957, 1997
[PubMed]
 
Smith TL, Volpe FR, Hashima JN, et al: Impact of a stimulant-focused enhanced program on the outcome of alcohol- and/or stimulant-dependent men. Alcohol Clin Exp Res 23:1772–1779, 1999
[PubMed]
 
Sullivan J, Sykora K, Schneiderman J, et al: Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar). Br J Addict 84:1353–1357, 1989
[PubMed]
 
Winters KC, Henly GA: Personal Experience Inventory Test and Manual. Los Angeles, CA, Western Psychological Services, 1989
 
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000
 
American Psychiatric Association Task Force on Benzodiazepine Dependency: Benzodiazepine Dependency, Toxicity, and Abuse. Washington, DC, American Psychiatric Association, 1990
 
Apelt S, Emrich HM: Sodium valproate in benzodiazepine withdrawal (letter). Am J Psychiatry 147:950–951, 1990
[PubMed]
 
Brady KT, Sonne S, Lydiard RB: Valproate treatment of comorbid panic disorder and affective disorders in two alcoholic patients (letter). J Clin Psychopharmacol 14:81–82, 1994
[PubMed]
 
Cavallaro R, Regazzetti MG, Covelli G, et al: Tolerance and withdrawal with zolpidem (letter). Lancet 342:374–375, 1993
[PubMed]
 
Chutuape MA, de Wit H: Relationship between subjective effects and drug preferences: ethanol and diazepam. Drug Alcohol Depend 34:243–251, 1994
[PubMed]
 
Ciraulo DA, Barnhill JG, Greenblatt DJ, et al: Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men. J Clin Psychiatry 49:333–337, 1988
[PubMed]
 
Calhoun SR, Wesson DR, Galloway GP, et al: Abuse of flunitrazepam (Rohypnol) and other benzodiazepines in Austin and South Texas. J Psychoactive Drugs 28:183–189, 1996
[PubMed]
 
Ernst E, Bartu A, Popescu A, et al: Methadone-related deaths in Western Australia 1993–99. Aust N Z J Public Health 26:364–370, 2002
[PubMed]
 
Griffiths R, Roache J: Abuse liability of benzodiazepines: a review of human studies evaluating subjective and/or reinforcing effects, in The Benzodiazepines: Current Standards for Medical Practice. Edited by Smith D, Wesson D. Hingham, MA, MTP Press, 1985, pp 209–225
 
Hammer BA, Brady KT: Valproate treatment of alcohol withdrawal and mania (letter). Am J Psychiatry 153:1232, 1996
[PubMed]
 
Hillbom M, Tokola R, Kuusela V, et al: Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid. Alcohol 6:223–226, 1989
[PubMed]
 
Hollister L, Motzenbecker E, Degan R: Withdrawal reactions from chlordiazepoxide (Librium). Psychopharmacologia 2:63–68, 1961
[PubMed]
 
Hollister LE, Bennett LL, Kimbell I, et al: Diazepam in newly admitted schizophrenics. Dis Nerv Syst 24:746–750, 1963
[PubMed]
 
Keck PE Jr, McElroy SL, Friedman LM: Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psychopharmacol 12 (suppl):36S–41S, 1992
 
Kintz P: Deaths involving buprenorphine: a compendium of French cases. Forensic Sci Int 121:65–69, 2001
[PubMed]
 
Klein E, Uhde TW, Post RM: Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal. Am J Psychiatry 143:235–236, 1986
[PubMed]
 
Ladner M: History of benzodiazepine dependence. J Subst Abuse Treat 8:53–59, 1991
 
Lawlor BA: Carbamazepine, alprazolam withdrawal, and panic disorder (letter). Am J Psychiatry 144:265–266, 1987
[PubMed]
 
McElroy SL, Keck PE Jr, Lawrence JM: Treatment of panic disorder and benzodiazepine withdrawal with valproate (letter). J Neuropsychiatry Clin Neurosci 3:232–233, 1991
[PubMed]
 
Neppe VM, Sindorf J: Carbamazepine for high-dose diazepam withdrawal in opiate users. J Nerv Ment Dis 179:234–235, 1991
[PubMed]
 
Richens A, Davidson DL, Cartlidge NE, et al: A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. J Neurol Neurosurg Psychiatry 57:682–687, 1994
[PubMed]
 
Rickels K, Case WG, Schweizer E, et al: Benzodiazepine dependence: management of discontinuation. Psychopharmacol Bull 26:63–68, 1990a
 
Rickels K, Schweizer E, Case WG, et al: Long-term therapeutic use of benzodiazepines, I: effects of abrupt discontinuation [published erratum appears in Arch Gen Psychiatry 48:51, 1991]. Arch Gen Psychiatry 47:899–907, 1990b
 
Ries RK, Roy-Byrne PP, Ward NG, et al: Carbamazepine treatment for benzodiazepine withdrawal. Am J Psychiatry 146:536–537, 1989
[PubMed]
 
Roy-Byrne PP, Ward NG, Donnelly PJ: Valproate in anxiety and withdrawal syndromes. J Clin Psychiatry 50 (suppl):44–48, 1989
 
Schweizer E, Rickels K, Case WG, et al: Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and outcome. Arch Gen Psychiatry 48:448–452, 1991
[PubMed]
 
Smith DE, Wesson DR: A new method for treatment of barbiturate dependence. JAMA 213:294–295, 1970
[PubMed]
 
Smith DE, Wesson DR: Phenobarbital technique for treatment of barbiturate dependence. Arch Gen Psychiatry 24:56–60, 1971
[PubMed]
 
Smith DE, Wesson DR: Benzodiazepine dependency syndromes. J Psychoactive Drugs 15:85–95, 1983
[PubMed]
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 7.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 33.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 23.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 50.  >
Topic Collections
Psychiatric News
PubMed Articles
[Citoflavin in the complex therapy of elderly patients with alcohol dependence syndrome.] Zh Nevrol Psikhiatr Im S S Korsakova 2014;114(5 Vypusk 2 Addiktivnye rasstroistva):73-78.
Alcohol use disorders and current pharmacological therapies: the role of GABAA receptors. Acta Pharmacol Sin 2014;35(8):981-93.doi:10.1038/aps.2014.50.
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation